What is Quinacrine-Induced Cardiomyopathy?
Quinacrine-Induced Cardiomyopathy is a rare but serious condition where the use of quinacrine, a medication historically used to treat malaria and autoimmune diseases, leads to damage of the heart muscle. This damage impairs the heart’s ability to pump blood effectively, potentially causing heart failure.

What Causes Quinacrine-Induced Cardiomyopathy?
The condition is caused by toxic effects of quinacrine on cardiac muscle cells. Possible mechanisms include:
- Direct myocardial toxicity from quinacrine accumulation
- Inflammatory reactions within the heart tissue
- Oxidative stress leading to cell damage
- Altered cardiac metabolism and fibrosis
- Prolonged or high-dose quinacrine therapy increasing risk
What Are the Symptoms of Quinacrine-Induced Cardiomyopathy?
Symptoms may develop gradually and include:
- Shortness of breath, especially with exertion
- Fatigue and weakness
- Swelling in the legs, ankles, or abdomen
- Palpitations or irregular heartbeat
- Chest discomfort or pain
- Lightheadedness or fainting in severe cases
How Is Quinacrine-Induced Cardiomyopathy Diagnosed?
Diagnosis involves:
- Medical history including quinacrine use and duration
- Physical examination showing signs of heart failure
- Echocardiogram to assess heart muscle function and structure
- Electrocardiogram (ECG) to detect arrhythmias or conduction abnormalities
- Blood tests for cardiac biomarkers and to exclude other causes
- Cardiac MRI or biopsy in selected cases for detailed evaluation

What Are the Treatment Options for Quinacrine-Induced Cardiomyopathy?
Treatment focuses on:
- Immediate discontinuation of quinacrine
- Standard heart failure therapies including diuretics, ACE inhibitors, beta-blockers, and others as needed
- Monitoring and managing arrhythmias
- Lifestyle modifications such as salt restriction and fluid management
- Regular follow-up with cardiology specialists
- Advanced therapies or devices in severe cases
Can Quinacrine-Induced Cardiomyopathy Cause Complications?
Yes, complications may include:
- Progressive heart failure leading to reduced quality of life
- Life-threatening arrhythmias
- Need for hospitalization or advanced heart therapies
- Increased risk of mortality if untreated
- Impact on other organs due to poor cardiac output


